Why Agile Therapeutics (AGRX) Stock Is Down 60%
Why Agile Therapeutics (AGRX) Stock Is Down 60%
Agile Therapeutics Inc (OTC:AGRX) shares are trading lower by 61% to $0.24 during Tuesday's session after the company announced the suspension of its trading on the Nasdaq effective Tuesday. The company received a final delisting notice from Nasdaq due to its failure to meet the minimum stockholders' equity requirement.
Agile Therapeutics Inc（場外交易代碼：AGRX）宣佈從週二起暫停在納斯達克的交易後，該公司股價在週二的交易中下跌了61％，至0.24美元。由於未能滿足最低股東權益要求，該公司收到了納斯達克的最終退市通知。
As a result, trading of its common stock on Nasdaq was suspended effective March 26. However, the company's shares will still be publicly traded on the over-the-counter market operated by the OTC Markets Group Inc. under the symbol AGRX.
結果，其在納斯達克的普通股自3月26日起暫停交易。但是，該公司的股票仍將在場外市場集團公司運營的場外交易市場上公開交易，股票代碼爲AGRX。
Agile Therapeutics added and emphasized that this transition will not impact its business operations and reaffirms its commitment to executing its business plan and exploring strategic opportunities to enhance Twirla growth and shareholder value.
Agile Therapeutics補充說，此次過渡不會影響其業務運營，並重申了其執行業務計劃和探索戰略機會以提高Twirla增長和股東價值的承諾。
According to data from Benzinga Pro, AGRX has a 52-week high of $12.25 and a 52-week low of $0.20.
根據Benzinga Pro的數據，AGRX的52周高點爲12.25美元，52周低點爲0.20美元。
譯文內容由第三人軟體翻譯。